F2 and chronic kidney disease: We observed that the patients with GAVE had a higher rebleeding rate than those with angiodysplasia despite no significant differences in platelet count, prothrombin time, activated partial thromboplastin time, or rates of end-stage renal disease and hepatoma between these 2 groups.